Showing results (421-430 of 1,398) with videos related to

Sort By:
Pageof 140
Drug Development Research|July 11, 2018
In silico and in vivo investigation of ferrocene-incorporated acyl ureas and homoleptic cadmium carboxylate derivatives for anticonvulsant, anxiolytic, and sedative potentialSadia Adil, Arif-Ullah Khan, Haroon Badshah, et al.
Drug Development Research|July 11, 2018
Anti-inflammatory and antinociceptive effects of tilifodiolide, isolated from Salvia tiliifolia Vahl (Lamiaceae)Marco Martin González-Chávez, Angel Josabad Alonso-Castro, Juan Ramón Zapata-Morales, et al.
Drug Development Research|April 18, 2018
A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitusZhenhai Shang, Feifei Han, Xueyan Zhou, et al.
Drug Development Research|June 30, 2009
EGFR Inhibition in the Treatment of Non-Small Cell Lung CancerDavid E Gerber
Drug Development Research|June 19, 2010
Targeting the Lipid Metabolic Pathways for the Treatment of MalariaChoukri Ben Mamoun, Sean T Prigge, Henri Vial
Drug Development Research|September 16, 2014
Ensemble Classification of Cancer Types and Biomarker IdentificationHussein Hijazi, Ming Wu, Aritro Nath, et al.
Drug Development Research|September 9, 2014
Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug developmentMarco Grados, Hyung Mo Sung, Sejin Kim, et al.
Drug Development Research|September 9, 2014
Advancing cancer patient care by integrating circulating tumor cell technology to understand the spatial and temporal dynamics of cancerMariam Rodriguez-Lee, Peter Kuhn, David R Webb
Drug Development Research|July 22, 2014
Early, middle, or late administration of zoledronate alleviates spontaneous nociceptive behavior and restores functional outcomes in a mouse model of CFA-induced arthritisCarlos Eduardo Morado-Urbina, Perla Abigail Alvarado-Vázquez, Rosa Mariana Montiel-Ruiz, et al.
Drug Development Research|December 22, 2015
The connection Between Plasma Protein Binding and Acute Toxicity as Determined by the LD50 ValueAndreas Svennebring
Pageof 140